Merz Pharma Gmbh & Co Kgaa

Umicore Ag & Co Kg

Markus Vogt

Karl-Anton Starz

Ralf Zuber

Sandra Wittpahl

Joachim Köhler

Matthias Binder

Gerhard Heinz

The present invention relates to a prefilled glass container, such as a prefilled glass syringe, comprising an aqueous botulinum toxin formulation. The aqueous botulinum toxin formulation in the prefilled container is stable at low to ambient temperature for a prolonged time period. Furthermore, the present invention relates to a kit comprising the botulinum toxin prefilled container, and to the use of the botulinum toxin prefilled container in therapeutic and cosmetic applications.

Botulinum toxin prefilled container

The present invention relates to a prefilled plastic container, such as a plastic syringe, comprising an aqueous botulinum toxin formulation. The aqueous botulinum toxin formulation in the prefilled plastic container is stable for a prolonged time period. Furthermore, the present invention relates to a kit comprising the prefilled plastic container, and to the use of the prefilled plastic container for therapeutic and cosmetic purposes.

Botulinum toxin prefilled plastic syringe

The present invention relates to a vial that is at least partially filled with an aqueous formulation of a neurotoxin, preferably botulinum toxin, to the manufacture of the vial and to the use thereof. The aqueous formulation of a neurotoxin is stable in the vial for a prolonged period of time.

Neurotoxin prefilled vial

The present invention relates a botulinum toxin prefilled syringe system with desirable injection force characteristics, in particular low gliding force and low break loose force, comprising a syringe barrel of glass containing a liquid botulinum toxin composition, a plunger stopper and a closure device such as a tip cap or a needle shield. In addition, the present invention relates to a kit comprising the botulinum toxin prefilled syringe system, and optionally instructions for use, and to the use of the botulinum toxin prefilled syringe system in therapeutic and cosmetic applications.

Botulinum toxin prefilled syringe system

The present invention relates to a prefilled glass container, such as a prefilled glass syringe, comprising an aqueoustoxin formulation. The aqueoustoxin formulation in the prefilled container is stable at low to ambient temperature for a prolonged time period. Furthermore, the present invention relates to a kit comprising thetoxin prefilled container, and to the use of thetoxin prefilled container in therapeutic and cosmetic applications.

Botulinum toxin prefilled glass syringe

A membrane electrode assembly for polymer electrolyte fuel cells consisting of a polymer electrolyte membrane, both faces of which are in contact with porous reaction layers and gas distributor layers. The reaction layers contain noble metal catalysts supported on carbon and a proton-conducting polymer, a so-called ionomer. At least one of the two reaction layers also contains a noble metal black.

Membrane electrode unit for polymer electrolyte fuel cells and a process for the production thereof

The present invention relates to a method for the production of a membrane electrode assembly comprising a polymer electrolyte membrane with two opposing membrane surfaces and a cathode and an anode electrode each comprising a catalyst layer and a gas distribution layer. Each catalyst layer is interposed between a membrane surface and the corresponding gas distribution layer. The catalyst layer of the cathode and/or the catalyst layer of the anode comprise at least two sub-layers. According to the present invention at least one of the sub-layers of the cathode electrode and/or the anode electrode is applied directly to the surface of the membrane while the remaining sub-layers are applied to the corresponding gas distribution layers. Finally the assembly of the coated membrane and the coated gas distribution layers is produced.

Growing community of inventors

Frankfurt am Main, Germany

Markus Vogt